Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy ... 7thSpace Interactive (press release) Methods: The Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy (3C) Study is a multicentre, open-label, randomized controlled trial with 800 participants which is addressing two important questions in kidney transplantation. |
